The UK's Doomed Medical Cannabis (Access) Bill

Published date10 February 2022
Subject MatterFood, Drugs, Healthcare, Life Sciences, Cannabis & Hemp, Food and Drugs Law
Law FirmBCL Solicitors LLP
AuthorMr David Hardstaff and John Binns

BCL Senior Associate, David Hardstaff and Partner, John Binns write for Open Access Government exploring the UK's doomed Medical Cannabis (Access) Bill.

*Here is a short extract from the article:

It is becoming difficult to remember a week in UK- parliamentary politics that wasn't defined by some sort of alleged scandal or drama. Against this backdrop, you may wonder how any actual work is done over and above the daily fighting of fires and attempts at political survival. For UK-based patients struggling to access much needed cannabis-based medicines, it has been difficult to be heard over the white noise of the daily news cycle. A notable and recent example of this is the 'talking out' of the Medical Cannabis (Access) Bill, a Private Member's Bill sponsored by Labour MP, Jeff Smith.

All controlled drugs in the UK are scheduled according to their potential harm and medical or therapeutic use. 2018 saw the apparent legalisation of medicinal cannabis in the UK, through the rescheduling of cannabis-based...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT